Madeleine Therapeutics Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
2
Madeleine Therapeutics General Information
Description
Operator of a biotechnology company intended to develop first-in-class antibody therapeutics targeting a novel cytokine pathway for autoimmune and inflammatory diseases. The company is currently operating in Stealth Mode.
Contact Information
Corporate Office
- 4 Rue Thenard
- 75005 Paris
- France
Corporate Office
- 4 Rue Thenard
- 75005 Paris
- France
Madeleine Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Jun-2026 | Completed | Stealth |
Madeleine Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AdBio partners | Venture Capital | Minority | ||
| Fountain Healthcare Partners | Venture Capital | Minority |
Madeleine Therapeutics FAQs
-
When was Madeleine Therapeutics founded?
Madeleine Therapeutics was founded in 2025.
-
Where is Madeleine Therapeutics headquartered?
Madeleine Therapeutics is headquartered in Paris, France.
-
What industry is Madeleine Therapeutics in?
Madeleine Therapeutics’s primary industry is Biotechnology.
-
Is Madeleine Therapeutics a private or public company?
Madeleine Therapeutics is a Private company.
-
What is Madeleine Therapeutics’s current revenue?
The current revenue for Madeleine Therapeutics is .
-
Who are Madeleine Therapeutics’s investors?
AdBio partners and Fountain Healthcare Partners have invested in Madeleine Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
